Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-26-053466
Filing Date
2026-05-07
Accepted
2026-05-07 18:25:11
Documents
1
Period of Report
2026-01-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3543
  Complete submission text file 0001213900-26-053466.txt   4968
Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address
McLaughlin Gerald W. (Reporting) CIK: 0001495412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41160 | Film No.: 26955328

Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Issuer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)